Scott JD - IRIDEX Executive Chairman

IRIX Stock  USD 1.72  0.02  1.15%   

Chairman

Scott JD is Executive Chairman of IRIDEX
Age 59
Address 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043
Phone650 940 4700
Webhttps://www.iridex.com

IRIDEX Management Efficiency

The company has return on total asset (ROA) of (0.2089) % which means that it has lost $0.2089 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5028) %, meaning that it created substantial loss on money invested by shareholders. IRIDEX's management efficiency ratios could be used to measure how well IRIDEX manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.21 in 2024. Return On Capital Employed is likely to rise to -0.28 in 2024. At this time, IRIDEX's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.5 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 4.4 M in 2024.
IRIDEX currently holds 2.75 M in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. IRIDEX has a current ratio of 3.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about IRIDEX's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 1 records

CHAIRMAN Age

Richard FerrariTenon Medical
70
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. Iridex Cp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 119 people. IRIDEX (IRIX) is traded on NASDAQ Exchange in USA. It is located in 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043 and employs 111 people. IRIDEX is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

IRIDEX Leadership Team

Elected by the shareholders, the IRIDEX's board of directors comprises two types of representatives: IRIDEX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IRIDEX. The board's role is to monitor IRIDEX's management team and ensure that shareholders' interests are well served. IRIDEX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IRIDEX's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Bruce, CEO President
Leigh Salvo, Head Relations
Patrick Mercer, Chief Officer
Fuad Ahmad, Interim Officer
Scott JD, Executive Chairman

IRIDEX Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IRIDEX a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for IRIDEX Stock Analysis

When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.